- Cardiometabolic monitoring kits
- Electrolytes Testing Kits
- Cardiac Markers Kits
- HbA1c Testing Kits
- Others
- Infectious disease testing kits
- HIV testing kits
- Hepatitis testing kits
- Respiratory infections testing kits
- Sexually-transmitted diseases (STDs) testing kits
- Influenza testing kits
- Others
- Pregnancy and fertility testing kits
- Fertility Testing Kits
- Pregnancy testing kits
- Glucose monitoring kits
- Hematology testing kits
- Fecal Occult Testing Kits
- Cholesterol Test Strips
- Drugs of Abuse Testing Kits
- Urinalysis Testing Kits
- Others
POC Immunoassay Testing Market size was valued at USD 42.6 billion in 2022 and is poised to grow at a CAGR of 10.2% from 2023-29. A Point-of-Care (POC) immunoassay testing refers to a diagnostic method conducted at or near the location where the patient is receiving medical care. Immunoassay tests are analytical methods that use the binding reaction between antibodies and antigens to detect and quantify specific substances in a patient's sample, such as blood, urine, or saliva. These tests are commonly used to diagnose various medical conditions, monitor disease progression, and assess treatment efficacy. The POC aspect of immunoassay testing is crucial as it allows for rapid results without the need for sending samples to a centralized laboratory. This immediacy is especially beneficial in urgent medical situations, remote locations, or scenarios where quick decisions are required, such as in emergency rooms, ambulances, primary care clinics, and home care settings.
Poc Immunoassay Testing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
10.20%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Market Dynamics Dynamics
The global POC immunoassay testing market is witnessing a rapid growth owing to advanced technology. The burgeoning the prevalence of infectious diseases, increased awareness among the patients regarding the POC immunoassay test kits are expected to witness the growth of POC immunoassay testing market. The promotional activities in order to increase awareness among the patient population regarding the modern testing techniques is expected to fuel growth of the market. The growing preference for home healthcare, increasing government support in the adoption of the POC immunoassay testing is witnessing to enhance the revenue share of the market. However, the high cost associated with testing procedure is expected to hamper the growth of the POC immunoassay testing market.
North-America Got Significant Share
POC Immunoassay Testing Market Regional Analysis
Geographically, global POC immunoassay testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North AmericaPOC immunoassay testing market is expanding at an unprecedented growth rate owing to its deep-rooted healthcare infrastructure. The growing awareness among the patient population regarding the modern improved testing techniques is expected to drive the growth of POC immunoassay testing market. The increasing healthcare expenditure, surge in awareness is expected to boost the growth of the market. The adoption of the new testing methods by the patient population is expected to offer enormous growth opportunities for the market players. The Asia Pacific POC immunoassay testing market is expected to show the growth in the forecasted period owing to its increasing patient pool coupled with improving technology.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Poc Immunoassay Testing Market Segmentation
By Product Type
By Platform
- Molecular Diagnostics
- Immunoassays
- Lateral Flow Assays
- Dipsticks
- Microfluidics
By End User
- Hospitals/Diagnostic centers
- Home Care
- Research Laboratories
- Others
Frequently Asked Questions
The POC Immunoassay Testing Market size was valued at USD 42.6 billion in 2022
The POC Immunoassay Testing Market Key Players are Abbott Laboratories (U.S.) Siemens (Germany) Roche (Switzerland) Hoffmann-La Roche Ltd (Switzerland) Thermo Fisher Scientific Inc. (U.S.) BD & Company (U.S.) bioMérieux SA (France)
The POC Immunoassay Testing Market regions are North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1.Executive Summary |
| 2.Global POC Immunoassay Testing Market Introduction |
| 2.1.Global POC Immunoassay Testing Market - Taxonomy |
| 2.2.Global POC Immunoassay Testing Market - Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Platform |
| 2.2.3. By End User |
| 2.2.4. By Region |
| 3.Global POC Immunoassay Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global POC Immunoassay Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global POC Immunoassay Testing Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Cardiometabolic monitoring kits |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Infectious disease testing kits |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Pregnancy and fertility testing kits |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Glucose monitoring kits |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Hematology testing kits |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Fecal Occult Testing Kits |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Cholesterol Test Strips |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Drugs of Abuse Testing Kits |
| 5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Urinalysis Testing Kits |
| 5.9.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 5.10. Others |
| 5.10.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.10.3. Market Opportunity Analysis |
| 6.Global POC Immunoassay Testing Market By Platform, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Molecular Diagnostics |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Immunoassays |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Lateral Flow Assays |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Dipsticks |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Microfluidics |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global POC Immunoassay Testing Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Hospitals/Diagnostic centers |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Home Care |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Research Laboratories |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global POC Immunoassay Testing Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America POC Immunoassay Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Cardiometabolic monitoring kits |
| 9.1.2.Infectious disease testing kits |
| 9.1.3.Pregnancy and fertility testing kits |
| 9.1.4.Glucose monitoring kits |
| 9.1.5.Hematology testing kits |
| 9.1.6.Fecal Occult Testing Kits |
| 9.1.7.Cholesterol Test Strips |
| 9.1.8.Drugs of Abuse Testing Kits |
| 9.1.9.Urinalysis Testing Kits |
| 9.1.10.Others |
| 9.2. Platform Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Molecular Diagnostics |
| 9.2.2.Immunoassays |
| 9.2.3.Lateral Flow Assays |
| 9.2.4.Dipsticks |
| 9.2.5.Microfluidics |
| 9.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals/Diagnostic centers |
| 9.3.2.Home Care |
| 9.3.3.Research Laboratories |
| 9.3.4.Others |
| 9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe POC Immunoassay Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cardiometabolic monitoring kits |
| 10.1.2.Infectious disease testing kits |
| 10.1.3.Pregnancy and fertility testing kits |
| 10.1.4.Glucose monitoring kits |
| 10.1.5.Hematology testing kits |
| 10.1.6.Fecal Occult Testing Kits |
| 10.1.7.Cholesterol Test Strips |
| 10.1.8.Drugs of Abuse Testing Kits |
| 10.1.9.Urinalysis Testing Kits |
| 10.1.10.Others |
| 10.2. Platform Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Molecular Diagnostics |
| 10.2.2.Immunoassays |
| 10.2.3.Lateral Flow Assays |
| 10.2.4.Dipsticks |
| 10.2.5.Microfluidics |
| 10.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals/Diagnostic centers |
| 10.3.2.Home Care |
| 10.3.3.Research Laboratories |
| 10.3.4.Others |
| 10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) POC Immunoassay Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cardiometabolic monitoring kits |
| 11.1.2.Infectious disease testing kits |
| 11.1.3.Pregnancy and fertility testing kits |
| 11.1.4.Glucose monitoring kits |
| 11.1.5.Hematology testing kits |
| 11.1.6.Fecal Occult Testing Kits |
| 11.1.7.Cholesterol Test Strips |
| 11.1.8.Drugs of Abuse Testing Kits |
| 11.1.9.Urinalysis Testing Kits |
| 11.1.10.Others |
| 11.2. Platform Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Molecular Diagnostics |
| 11.2.2.Immunoassays |
| 11.2.3.Lateral Flow Assays |
| 11.2.4.Dipsticks |
| 11.2.5.Microfluidics |
| 11.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals/Diagnostic centers |
| 11.3.2.Home Care |
| 11.3.3.Research Laboratories |
| 11.3.4.Others |
| 11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) POC Immunoassay Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cardiometabolic monitoring kits |
| 12.1.2.Infectious disease testing kits |
| 12.1.3.Pregnancy and fertility testing kits |
| 12.1.4.Glucose monitoring kits |
| 12.1.5.Hematology testing kits |
| 12.1.6.Fecal Occult Testing Kits |
| 12.1.7.Cholesterol Test Strips |
| 12.1.8.Drugs of Abuse Testing Kits |
| 12.1.9.Urinalysis Testing Kits |
| 12.1.10.Others |
| 12.2. Platform Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Molecular Diagnostics |
| 12.2.2.Immunoassays |
| 12.2.3.Lateral Flow Assays |
| 12.2.4.Dipsticks |
| 12.2.5.Microfluidics |
| 12.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals/Diagnostic centers |
| 12.3.2.Home Care |
| 12.3.3.Research Laboratories |
| 12.3.4.Others |
| 12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America POC Immunoassay Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cardiometabolic monitoring kits |
| 13.1.2.Infectious disease testing kits |
| 13.1.3.Pregnancy and fertility testing kits |
| 13.1.4.Glucose monitoring kits |
| 13.1.5.Hematology testing kits |
| 13.1.6.Fecal Occult Testing Kits |
| 13.1.7.Cholesterol Test Strips |
| 13.1.8.Drugs of Abuse Testing Kits |
| 13.1.9.Urinalysis Testing Kits |
| 13.1.10.Others |
| 13.2. Platform Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Molecular Diagnostics |
| 13.2.2.Immunoassays |
| 13.2.3.Lateral Flow Assays |
| 13.2.4.Dipsticks |
| 13.2.5.Microfluidics |
| 13.3. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals/Diagnostic centers |
| 13.3.2.Home Care |
| 13.3.3.Research Laboratories |
| 13.3.4.Others |
| 13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Abbott Laboratories (U.S.) |
| 14.2.2.Siemens (Germany) |
| 14.2.3.Roche (Switzerland) |
| 14.2.4.Hoffmann-La Roche Ltd (Switzerland) |
| 14.2.5.Thermo Fisher Scientific Inc. (U.S.) |
| 14.2.6.BD & Company (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Abbott Laboratories (U.S.)
- Siemens (Germany)
- Roche (Switzerland)
- Hoffmann-La Roche Ltd (Switzerland)
- Thermo Fisher Scientific Inc. (U.S.)
- BD & Company (U.S.)
- bioMérieux SA (France)